Replies to post #426752 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Positive findings were reported more quickly than negative ones (median of 272; 95% CI, 211-318 days vs 407; 95% CI, 298-705 days; log-rank P < .001).

And how does that read with NWBO now being around 430?

[FeMike]

Woof. Where to begin? Your first bullet point is overwhelming negative, probably shouldn't have started with that.

Positive findings were reported more quickly than negative ones (median of 272; 95% CI, 211-318 days vs 407; 95% CI, 298-705 days; log-rank P < .001).

So you're saying studies show that, on average, the longer it takes to release results the more likely it is they are negative? Interesting. So with positive findings being reported a median of 272 days after announcing TLD which we are likely going to double, that doesn't bode well.

Timeout....you also said that these timelines are:

300 days in median time from announcing positive results to publication

So this isn't even from data lock, it's from TLD. We haven't even released TLD yet so this entire comparison is useless. Care to find me average time for positive results to be announced in TLD?

Ah, wait wait, I forgot we're intentionally not releasing TLD so we can trap the shorts and protect our share price. Wouldn't want to screw over investors by allowing the price to fall 75% over our year of silence now would we? Clever Linda...

Point number two, Kristyn Power. You tying this to the trial is complete speculation and unsubstantiated. You are more than welcome to glean whatever you want from it for your investment thesis but it is 100% not an update on the trial.

3) See #2

4) This was standard housekeeping. This is being done regardless of the DCVax-L results. Not an update on the trial.

5) Manufacturing update, not a trial update

6) Manufacturing update, not a trial update

7) Manufacturing update, not a trial update

8) Prevents the company from going bankrupt, not a trial update.

9) Lykiri's DD confirms the endpoint acceptance overseas, which we already knew because that DD was done back when ATL discovered the updated endpoints in 2020. Not new.

10) Manufacturing update, and speculation.

Give me an update on the trial since Oct 2020.

[iclight]

NWBO has hired other industry experts before that were supposed to lead to TLD. Didn't happen.

Sawston has been hyped as "must get results soon because look at the Sawston progress" for at least 5 years. More of the same.

Advent is the new Cognate. No relevance for NWBO shareholders.

Patents to things that don't work are irrelevant. See my link to the DCVax-Prostate patent.

Ihub posters have been digging up "DD" for 8+ years that were all going to lead to a big party in the Bahamas. And here the SP sits at .65 with no end of the trial in sight

[JRIII]

Why do you continue to post the study about how long it takes companies to go from positive TLD to publication? We don't have positive TLD! This study is completely meaningless. It has no relevance to NWBO until they release TLD.

Why are they refusing to release TLD? Where is the data they promised in September 2020 (and in early July before that)? What could possibly have happened after they locked the data and became unblinded that would make them not want to release it? Gee, I wonder. Seems so strange. I'm just baffled at what could have happened after they took a look at the data that made them not want to release it. I just can't figure it out. What could they have seen? It's just an enigma wrapped inside a mystery.

Dutch Boy: